<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04890145</url>
  </required_header>
  <id_info>
    <org_study_id>2020VIB010</org_study_id>
    <nct_id>NCT04890145</nct_id>
  </id_info>
  <brief_title>The RW-Precision-Coupler Clinical Investigation</brief_title>
  <official_title>The RW-Precision-Coupler Clinical Investigation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>MED-EL Elektromedizinische Ger채te GesmbH</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>MED-EL Elektromedizinische Ger채te GesmbH</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The RW-Precision-Coupler Clinical Investigation is prospective, non-randomized, open label,&#xD;
      single subjects repeated measures, longitudinal monocentric trial. The primary aim of this&#xD;
      pre-market clinical investigation is to evaluate the clinical performance and safety of VSB&#xD;
      together with the VSB RWP-Coupler in the treatment of hearing loss. As secondary aims are to&#xD;
      evaluate the clinical performance of VSB together with RWP-Coupler by measuring Sound Field&#xD;
      audiometry (SF), to evaluate the safety of VSB together with RWP-Coupler by measuring bone&#xD;
      conduction (BC) thresholds and collecting and assessing adverse events.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 19, 2021</start_date>
  <completion_date type="Anticipated">March 31, 2024</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Freiburger Monosyllable Test</measure>
    <time_frame>6 months post-operative</time_frame>
    <description>Investigate the improvement of unaided pre-activation Word Recognition Scores (WRS) to 6 months post-operation aided WRS with RW-Precision-Coupler</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Hearing Loss</condition>
  <arm_group>
    <arm_group_label>Mild to severe hearing loss</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>RW-Precision-Coupler</intervention_name>
    <description>Implantation of the RW-Precision-Coupler together with FMT-VORP 503</description>
    <arm_group_label>Mild to severe hearing loss</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Geographically and physically able to return to the investigational site for scheduled&#xD;
             evaluations and follow-up appointments&#xD;
&#xD;
               -  Fluent in the German language&#xD;
&#xD;
               -  Persons of 18 years of age or older&#xD;
&#xD;
               -  Signed and dated informed consent before the start of any study-specific&#xD;
                  procedure&#xD;
&#xD;
               -  The physician must fully assess the potential risks and benefits for the patient&#xD;
                  prior to the decision to implant the RW-Precision-Coupler. The physician must&#xD;
                  exercise medical judgment and consider the patient's complete hospital record&#xD;
                  (also called medical history)&#xD;
&#xD;
               -  No previous active middle ear implant surgery performed in the implanted ear&#xD;
&#xD;
               -  The following indication for VORP503:&#xD;
&#xD;
                    -  For a patient with sensorineural hearing loss, pure-tone air conduction&#xD;
                       threshold levels at or within the levels listed below:&#xD;
&#xD;
                    -  For a patient with conductive or mixed hearing loss, pure tone&#xD;
                       bone-conduction threshold levels at or within the levels listed below:&#xD;
&#xD;
                    -  A patient shall present with an ear anatomy that can facilitate positioning&#xD;
                       of the FMT in contact with a suitable vibratory structure of the ear.&#xD;
&#xD;
                    -  A patient with sensorineural hearing loss shall be a current user of an&#xD;
                       acoustic hearing aid and have used this aid for at least 4 hours (average)&#xD;
                       per day for at least 3 months prior to evaluation, or shall not be able to&#xD;
                       wear or benefit from conventional hearing aids for medical reasons.&#xD;
&#xD;
                    -  A patient shall be psychologically and emotionally stable with realistic&#xD;
                       expectations of the benefits and limitations of the Soundbridge&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Simultaneous participation in another clinical trial (on device or on drug) which&#xD;
             would interfere with the results of the study&#xD;
&#xD;
               -  Pregnancy or lactation&#xD;
&#xD;
               -  Contraindication for RWP-Coupler Sizer:&#xD;
&#xD;
                    -  if a patient is known to be intolerant of the materials used in the&#xD;
                       RWP-Coupler.&#xD;
&#xD;
                    -  if a patient is known to be intolerant of the materials used in the&#xD;
                       RWP-Coupler Sizer.&#xD;
&#xD;
                    -  in case of a fixed stapes footplate.&#xD;
&#xD;
               -  Contraindication for VORP503:&#xD;
&#xD;
                    -  A patient is known to be intolerant of the materials used in the implant&#xD;
                       (medical grade silicone elastomer, medical grade epoxy and titanium).&#xD;
&#xD;
                    -  A patient with retrocochlear, or central auditory disorders.&#xD;
&#xD;
                    -  A patient with nonresponsive active ear infection and/or chronic fluid in or&#xD;
                       about the ear.&#xD;
&#xD;
                    -  A patient whose hearing loss has demonstrated an improving and decreasing&#xD;
                       fluctuation over a two-year period of 15 dB in either direction.&#xD;
&#xD;
                    -  A patient with any physical, psychological, or emotional disorder that would&#xD;
                       interfere with surgery or the ability to perform on test and rehabilitation&#xD;
                       procedures.&#xD;
&#xD;
                    -  A patient with a skin or scalp condition that may preclude attachment of the&#xD;
                       audio processor with a magnet.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lenarz Thomas, Prof. h.c. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medizinische Hochschule Hannover Klinik und Poliklinik f체r Hals-Nasen-Ohren-Heilkunde</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Severin F체rhapter, PhD</last_name>
    <phone>+4357788</phone>
    <phone_ext>5254</phone_ext>
    <email>allclinicalresearchvibrant@medel.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Gabriella Bock, PhD</last_name>
    <phone>+4357788</phone>
    <phone_ext>1157</phone_ext>
    <email>allclinicalresearchvibrant@medel.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Medical School Hannover</name>
      <address>
        <city>Hannover</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Lenarz, Prof. Prof. h.c. Dr</last_name>
      <phone>+49 511 532</phone>
      <phone_ext>6565</phone_ext>
      <email>lenarz.thomas@mh-hannover.de</email>
    </contact>
    <contact_backup>
      <last_name>Nils Prenzler, Dr.</last_name>
      <phone>+49 511 532</phone>
      <phone_ext>5558</phone_ext>
      <email>Prenzler.Nils@mh-hannover.de</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 12, 2021</study_first_submitted>
  <study_first_submitted_qc>May 12, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 18, 2021</study_first_posted>
  <last_update_submitted>May 26, 2021</last_update_submitted>
  <last_update_submitted_qc>May 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Vibrant Soundbridge System</keyword>
  <keyword>RW-Precision-Coupler</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hearing Loss</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

